Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03593200 |
|---|---|
| Brief Title: | A Phase IIa Study to Assess the Safety, Efficacy, and Pharmacokinetics of Subcutaneously Administered Pegcetacoplan (APL-2) in Subjects With PNH |
| First Submitted : | June 28, 2018 |
| First Submitted that Met QC Criteria : | July 10, 2018 |
| First Posted : | July 20, 2018 |
| Results First Submitted : | August 4, 2020 |
| Results First Posted with QC Comments : | August 18, 2020 |
| Results First Submitted that Met QC Criteria : | December 21, 2020 |
| Results First Posted : | December 22, 2020 |
| Last Update Submitted that Met QC Criteria : | December 21, 2020 |
| Last Update Posted : | December 22, 2020 |